Further analysis of the two mortality-associated modules identified a gene panel of FNDC3B, VSTM1, PLA2G4A, GOLGA3 and CALR. Hierarchical clustering analysis of the five genes enabled the identification of a subgroup of AML patients with favourable OS. The gene discussed is VSTM1; the disease is acute myeloid leukemia.